Vanguard Group
ENTA icon

Vanguard Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.9M Sell
1,976,672
-30,761
-2% -$233K ﹤0.01% 2702
2025
Q1
$11.1M Buy
2,007,433
+23,269
+1% +$128K ﹤0.01% 2788
2024
Q4
$11.4M Buy
1,984,164
+2,298
+0.1% +$13.2K ﹤0.01% 2883
2024
Q3
$20.5M Buy
1,981,866
+47,476
+2% +$492K ﹤0.01% 2584
2024
Q2
$25.1M Buy
1,934,390
+6,312
+0.3% +$81.9K ﹤0.01% 2455
2024
Q1
$33.7M Buy
1,928,078
+134,292
+7% +$2.34M ﹤0.01% 2343
2023
Q4
$16.9M Buy
1,793,786
+133,266
+8% +$1.25M ﹤0.01% 2673
2023
Q3
$18.5M Sell
1,660,520
-45,655
-3% -$510K ﹤0.01% 2576
2023
Q2
$36.5M Buy
1,706,175
+169,272
+11% +$3.62M ﹤0.01% 2330
2023
Q1
$62.2M Buy
1,536,903
+14,714
+1% +$595K ﹤0.01% 2071
2022
Q4
$70.8M Buy
1,522,189
+45,279
+3% +$2.11M ﹤0.01% 1991
2022
Q3
$76.6M Sell
1,476,910
-39,779
-3% -$2.06M ﹤0.01% 1954
2022
Q2
$71.7M Sell
1,516,689
-72,535
-5% -$3.43M ﹤0.01% 2006
2022
Q1
$113M Sell
1,589,224
-36,685
-2% -$2.61M ﹤0.01% 1871
2021
Q4
$122M Sell
1,625,909
-174,454
-10% -$13M ﹤0.01% 1881
2021
Q3
$102M Sell
1,800,363
-56,656
-3% -$3.22M ﹤0.01% 1964
2021
Q2
$81.7M Sell
1,857,019
-41,655
-2% -$1.83M ﹤0.01% 2108
2021
Q1
$93.6M Buy
1,898,674
+98,095
+5% +$4.84M ﹤0.01% 1981
2020
Q4
$75.8M Buy
1,800,579
+79,689
+5% +$3.35M ﹤0.01% 1979
2020
Q3
$78.8M Buy
1,720,890
+30,093
+2% +$1.38M ﹤0.01% 1803
2020
Q2
$84.9M Buy
1,690,797
+537
+0% +$27K ﹤0.01% 1754
2020
Q1
$86.9M Sell
1,690,260
-7,469
-0.4% -$384K ﹤0.01% 1604
2019
Q4
$105M Buy
1,697,729
+10,881
+0.6% +$672K ﹤0.01% 1727
2019
Q3
$101M Buy
1,686,848
+66,198
+4% +$3.98M ﹤0.01% 1717
2019
Q2
$137M Sell
1,620,650
-2,641
-0.2% -$223K 0.01% 1582
2019
Q1
$155M Buy
1,623,291
+97,457
+6% +$9.31M 0.01% 1504
2018
Q4
$108M Buy
1,525,834
+99,043
+7% +$7.02M ﹤0.01% 1636
2018
Q3
$122M Buy
1,426,791
+330,374
+30% +$28.2M ﹤0.01% 1703
2018
Q2
$127M Buy
1,096,417
+230,026
+27% +$26.7M 0.01% 1656
2018
Q1
$70.1M Buy
866,391
+44,704
+5% +$3.62M ﹤0.01% 1897
2017
Q4
$48.2M Sell
821,687
-15,876
-2% -$932K ﹤0.01% 2076
2017
Q3
$39.2M Sell
837,563
-9,458
-1% -$443K ﹤0.01% 2162
2017
Q2
$30.5M Buy
847,021
+54,856
+7% +$1.97M ﹤0.01% 2266
2017
Q1
$24.4M Buy
792,165
+53,007
+7% +$1.63M ﹤0.01% 2367
2016
Q4
$24.8M Buy
739,158
+42,281
+6% +$1.42M ﹤0.01% 2326
2016
Q3
$18.5M Buy
696,877
+46,317
+7% +$1.23M ﹤0.01% 2394
2016
Q2
$14.3M Buy
650,560
+19,071
+3% +$421K ﹤0.01% 2477
2016
Q1
$18.5M Buy
631,489
+15,461
+3% +$454K ﹤0.01% 2333
2015
Q4
$20.3M Buy
616,028
+42,348
+7% +$1.4M ﹤0.01% 2301
2015
Q3
$20.7M Buy
573,680
+265,798
+86% +$9.61M ﹤0.01% 2279
2015
Q2
$13.9M Buy
307,882
+23,406
+8% +$1.05M ﹤0.01% 2513
2015
Q1
$8.71M Buy
284,476
+21,030
+8% +$644K ﹤0.01% 2707
2014
Q4
$13.4M Buy
263,446
+21,186
+9% +$1.08M ﹤0.01% 2415
2014
Q3
$9.59M Buy
242,260
+62,350
+35% +$2.47M ﹤0.01% 2514
2014
Q2
$7.75M Buy
179,910
+12,279
+7% +$529K ﹤0.01% 2634
2014
Q1
$6.7M Buy
167,631
+118,512
+241% +$4.74M ﹤0.01% 2683
2013
Q4
$1.34M Buy
49,119
+18,489
+60% +$504K ﹤0.01% 3334
2013
Q3
$702K Sell
30,630
-196
-0.6% -$4.49K ﹤0.01% 3463
2013
Q2
$546K Buy
+30,826
New +$546K ﹤0.01% 3452